Word

STEM CELL SCIENCES

Status

Dead

Status Code

602

Status Date

Tuesday, November 7, 2023

Serial Number

97392934

Mark Type

4000

Filing Date

Tuesday, May 3, 2022

Abandoned Date

Wednesday, September 13, 2023

Trademark Owner History

Todd Frank Ovokaitys

Classifications

5 Stem cells for medical purposes; pharmaceuticals derived from stem cells and used for anti-aging, age reversal, and for the treatment of cardiac disease, neurodegenerative disease, musculoskeletal trauma, neurological trauma, type 1 diabetes, liver disease, lung disease, pancreatic disease, psychosis, and psychiatric disorder; Nutraceuticals for use as a dietary supplement; Nutraceuticals for the treatment of or reversal of aging and age-related disease; nutraceuticals for use as a dietary supplement for the intended benefit of reversing the aging process and age-related disease; Nutraceuticals derived from stem cells and for use as a dietary supplement for the intended benefit of reversing the aging process and age-related disease; Nutraceuticals for use as a dietary supplement for the intended benefit of anti-aging, age reversal, treatment of cardiac disease, neurodegenerative disease, musculoskeletal trauma, neurological trauma, type 1 diabetes, liver disease, lung disease, pancreatic disease, psychosis, and psychiatric disorder; Nutraceuticals derived from stem cells for use as a dietary supplement for the intended benefit of anti-aging, age reversal, treatment of cardiac disease, neurodegenerative disease, musculoskeletal trauma, neurological trauma, type 1 diabetes, liver disease, lung disease, pancreatic disease, psychosis, and psychiatric disorder

44 Stem cell therapy services; medical services relating to the removal, treatment, and processing of stem cells; Medical services to slow or reverse human biological aging processes; anti-aging or longevity medical services; Medical services relating to the treatment of cardiac disease, a neurodegenerative disease, a musculoskeletal trauma, a neurological trauma, type 1 diabetes, liver disease, lung disease, pancreatic disease, psychosis, and psychiatric disorder; medical services, namely, the administration of compositions to humans for the purpose of slowing or reversing human biological aging processes, treating cardiac disease, treating neurodegenerative disease, treating musculoskeletal trauma, treating neurological trauma, treating type 1 diabetes, treating liver disease, treating lung disease, treating pancreatic disease, treating psychosis, and treating psychiatric disorder; medical services, namely, the administration of stem-cell based compositions to humans for the purpose of slowing or reversing human biological aging processes, treating cardiac disease, treating neurodegenerative disease, treating musculoskeletal trauma, treating neurological trauma, treating type 1 diabetes, treating liver disease, treating lung disease, treating pancreatic disease, treating psychosis, and treating psychiatric disorder; medical services, namely, stem-cell based treatments for the purpose of slowing or reversing human biological aging processes, treating cardiac disease, treating neurodegenerative disease, treating musculoskeletal trauma, treating neurological trauma, treating type 1 diabetes, treating liver disease, treating lung disease, treating pancreatic disease, treating psychosis, and treating psychiatric disorder

Trademark Events

Nov 8, 2023

Abandonment Notice E-Mailed - Failure To Respond

Nov 7, 2023

Abandonment Notice Mailed - Failure To Respond

Nov 7, 2023

Abandonment - Failure To Respond Or Late Response

Jun 8, 2023

Application Extension Granted/Receipt Provided

Jun 8, 2023

Application Extension To Response Period - Received

Mar 12, 2023

Notification Of Non-Final Action E-Mailed

Mar 12, 2023

Non-Final Action E-Mailed

Mar 12, 2023

Non-Final Action Written

Feb 21, 2023

Assigned To Examiner

May 7, 2022

New Application Office Supplied Data Entered

May 6, 2022

New Application Entered